Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostate Adenocarcinoma × Neoadjuvant Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 23 Rectal Neoplasms 20 Colorectal Neoplasms 15 Esophageal Neoplasms 13 Pancreatic Neoplasms 11 Lung Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Prostatic Neoplasms 10 Adenocarcinoma Of Esophagus 8 Head and Neck Neoplasms 7 Esophageal Squamous Cell Carcinoma 7 Stomach Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Ovarian Neoplasms 6 Urinary Bladder Neoplasms 4 Sarcoma 4 Neoplasms 4 Colonic Neoplasms 4 Central Nervous System Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 4 Brain Neoplasms 4 Inflammatory Breast Neoplasms 3 Fallopian Tube Neoplasms 3 Breast Neoplasms, Male 3 Breast Carcinoma In Situ 3 Urethral Neoplasms 2 Teratoma 2 Solitary Fibrous Tumor, Pleural 2 Recurrence 2 Neuroblastoma 2

Interventions

niraparib 1 Surveys and Questionnaires 1 Receptors, Bombesin 1 Radiotherapy 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Radiation 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Gallium 1 Estramustine 1 Docetaxel 1 Diet Therapy 1 Carboplatin 1 BAY 86-7548 1 Adjuvants, Pharmaceutic 1 68Ga-bombesin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02175212 2020-11-20

AADLPC

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Phase 3 Completed

362 enrolled 17 charts

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡